Peptides

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of RAB3IL1 antibody, catalog no. 70R-3159</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PANK4 antibody, catalog no. 70R-2711</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of GLO1 antibody, catalog no. 70R-2994</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of UTP23 antibody, catalog no. 70R-10099</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PRPH antibody, catalog no. 70R-2613</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of C12orf4 antibody, catalog no. 70R-3498</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DERL3 antibody, catalog no. 70R-6365</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MKRN2 antibody, catalog no. 70R-2130</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of RALYL antibody, catalog no. 70R-4982</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of HELLS antibody, catalog no. 70R-4647</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of INSR antibody, catalog no. 70R-7510</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of RPL10A antibody, catalog no. 70R-3210</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Abcb10 antibody, catalog no. 70R-8569</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of NR2C2 antibody, catalog no. 70R-5229</p>

HIV-1 p17 Gag (77-85), also called SL9, is a short part of the Human Immunodeficiency Virus 1 especially a short peptide of matrix composed of the viral protein p17 ensuring the integrity of the virion particle. HIV-1 p17 Gag (77-85) HLA-A*02:01-restricted was one of the first cytotoxic T lymphocytes epitope identified for HIV-1. It produces a specific cytotoxic T cells response in 75% of chronically infected adults but a rare activity in acute infection. Therefore, HIV-1 p17 Gag (77-85) may serve as target for anticancer immunotherapeutic strategies especially for vaccine development. Applications of HIV-1 p17 Gag (77-85): HIV-1 p17 Gag (77-85) is used to stimulate CTL responses in peripheral blood mononuclear cells (PBMCs). Then, ELISPOT assay is used to quantify peptide epitope specificity and IFN-γ releasing effector cells. Potential cross-reactivities with FluM1 (58-66) and HCV NS5B (2594-2602): Moreover, HIV-1 p17 Gag (77-85) share similarities with FluM1 (58-66) which can potentially show a cross-reactivity between these epitopes. It has been demonstrated a cross-reactivity and results suggest that immunity following infection by Influenza virus causes specific immune response to HIV-1 p17 Gag (77-85). Similarities between two others HLA-A2-restricted epitopes of two viruses have been demonstrated too: the amino acid sequence of HIV-1 p17 Gag (77-85) (SLYNTVATL) and of HCV NS5B (2594-2602) (ALYDVVTKL). Therefore, researches are conducted to know if during HCV/HIV co-infection it could be exist a T cell cross reactivity.

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PMM1 antibody, catalog no. 70R-3894</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TRIT1 antibody, catalog no. 70R-8332</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZDHHC19 antibody, catalog no. 70R-6343</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PDIA4 antibody, catalog no. 70R-7388</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of KCNIP2 antibody, catalog no. 70R-5098</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF205 antibody, catalog no. 70R-8254</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZADH2 antibody, catalog no. 70R-4445</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DBT antibody, catalog no. 70R-2499</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of HOXA11 antibody, catalog no. 70R-9590</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TWF1 antibody, catalog no. 70R-3895</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PLD2 antibody, catalog no. 70R-7964</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LCA5 antibody, catalog no. 70R-3735</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CPSF3 antibody, catalog no. 70R-1351</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CHCHD8 antibody, catalog no. 70R-9459</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SIP1 antibody, catalog no. 70R-4677</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ABP1 antibody, catalog no. 70R-5440</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of KCNC4 antibody, catalog no. 70R-5155</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ADH4 antibody, catalog no. 70R-2378</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CPS1 antibody, catalog no. 70R-1111</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of NR4A3 antibody, catalog no. 70R-3103</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZBTB26 antibody, catalog no. 70R-8354</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of BCO2 antibody, catalog no. 70R-10117</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CHIC2 antibody, catalog no. 70R-6864</p>

A synthetic peptide for use as a blocking control in assays to test for specificity of LGALS3BP antibody, catalog no. 70R-6085

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of C20orf141 antibody, catalog no. 70R-4134</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF131 antibody, catalog no. 70R-8710</p>

<p>Amino-dPEG®8-t-boc-hydrazide is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Amino-dPEG®8-t-boc-hydrazide is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of FTH1 antibody, catalog no. 70R-5763</p>

A synthetic peptide for use as a blocking control in assays to test for specificity of IMPG2 antibody, catalog no. 70R-7479

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of KLHDC8B antibody, catalog no. 70R-3670</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of OSBPL8 antibody, catalog no. 70R-6725</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of FBXL3 antibody, catalog no. 70R-2129</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of HINT1 antibody, catalog no. 70R-4222</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of FOXO3A antibody, catalog no. 70R-8237</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CHRNA5 antibody, catalog no. 70R-8064</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MCM10 antibody, catalog no. 70R-5512</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of XAF1 antibody, catalog no. 70R-3725</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MICAL1 antibody, catalog no. 70R-10397</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MCM7 antibody, catalog no. 70R-1609</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DENND1B antibody, catalog no. 70R-7075</p>

A synthetic peptide for use as a blocking control in assays to test for specificity of CCIN antibody, catalog no. 70R-2923

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SLC1A5 antibody, catalog no. 70R-1769</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Ppp2r5e antibody, catalog no. 70R-9426</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of BAG5 antibody, catalog no. 70R-10407</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TNNT3 antibody, catalog no. 70R-1233</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DCP1B antibody, catalog no. 70R-8999</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TSKS antibody, catalog no. 70R-2687</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of RAPSN antibody, catalog no. 70R-2650</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MAP4 antibody, catalog no. 70R-10032</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZCCHC12 antibody, catalog no. 70R-2560</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of RG9MTD1 antibody, catalog no. 70R-4805</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZDHHC3 antibody, catalog no. 70R-9819</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of FAM120A antibody, catalog no. 70R-2701</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MAPKAPK3 antibody, catalog no. 70R-10036</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MMP23B antibody, catalog no. 70R-6358</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZBTB40 antibody, catalog no. 70R-8028</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MCEE antibody, catalog no. 70R-10039</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ALS2CR12 antibody, catalog no. 70R-9192</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of RABGGTA antibody, catalog no. 70R-2976</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SPIon Channel antibody, catalog no. 20R-1185</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ACO1 antibody, catalog no. 70R-4994</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CRLF1 antibody, catalog no. 70R-8187</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SLC25A36 antibody, catalog no. 70R-6399</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TEC antibody, catalog no. 70R-4469</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of EPHX1 antibody, catalog no. 70R-5355</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LARP6 antibody, catalog no. 70R-4880</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MDH1 antibody, catalog no. 70R-1116</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PCGF5 antibody, catalog no. 70R-3094</p>

<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZXDC antibody, catalog no. 70R-8902</p>

<p>Amino-dPEG®12-Tris (-dPEG®24-t-butyl ester)3 is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Amino-dPEG®12-Tris (-dPEG®24-t-butyl ester)3 is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.</p>

<p>CNP-53 is a Research Tool for the study of protein interactions, pharmacology and cell biology. It is an activator that interacts with Ligand Receptor and Cell Biology. CNP-53 is a peptide with a molecular weight of 5310.1 Da, which is purified to be 99% pure. This product is suitable for use in research as well as in clinical trials and has been shown to inhibit ion channels and high purity proteins.</p>

<p>[Pyr1]apelin-13 (human) (CAS: 217082-60-5)</p>

Portion of CMV pp65

<p>Lipoamido-dPEG®8-TFP Ester is a PEG molecule conjugated with a lipid moiety. Lipoamido-dPEG®8-TFP Ester, conjugated to this lipid constituent, is very important especially in drug delivery and vaccine development as it helps improve the stability and circulation time of lipid nanoparticles (LNPs) and liposomes.</p>

<p>SARS Coronavirus is an enveloped virus containing 3 outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein takes part in the virus infection cycle and is the primary target of neutralizing antibodies. The recombinant SARS Spike containing a total of 220 amino acids (306-515) and having a calculated M.W. of 24.8 kDa.SARS Spike  is fused to a 6 amino acid His-tag at C-terminus, and is purified by proprietary chromatographic techniques. Of a HEK293 source the formulation of the SARS Spike (306-515) solution (0.5mg/ml) contains Phosphate-Buffered Saline (pH 7.4) and 10% Glycerol.<br>One-Letter Formula: DGSMRVVPSG DVVRFPNITN LCPFGEVFNA TKFPSVYAWE RKKISNCVAD YSVLYNSTFF STFKCYGVSA TKLNDLCFSN VYADSFVVKG DDVRQIAPGQ TGVIADYNYK LPDDFMGCVL AWNTRNIDAT STGNYNYKYR YLRHGKLRPF ERDISNVPFS PDGKPCTPPA LNCYWPLNDY GFYTTTGIGY QPYRVVVLSF ELLNAPATVC GPKLHHHHHH</p>

<p>Anti NPY (1-19) is a peptide that binds to the NPY receptor. It is an agonist of the NPY receptor, which is a G-protein coupled receptor. This peptide has been shown to activate ion channels, such as nicotinic acetylcholine receptors and glutamate receptors. Anti NPY (1-19) has also been shown to inhibit ligand binding to the NPY receptor, and may be used as a research tool for studying this receptor in cell biology.</p>

The 2'-5' oligoadenylate synthetase 1 (2-5A-1) is a protein that in humans is encoded by the OAS1 gene. This enzyme catalyzes the synthesis of 2'-5' oligoadenylates, which are potent activators of PKC and MAPK. 2-5A-1 has been shown to increase intracellular calcium levels, activate PKC and MAPK, and induce apoptosis in human cells.

<p>AIP-III is a peptide that belongs to the group of activators. It binds to the nicotinic acetylcholine receptor, thereby activating it. AIP-III has been shown to cause significant changes in the activity of ion channels and is used as a research tool for pharmacology and protein interactions. AIP-III has been found to be a potent inhibitor of various types of cancer cells in cell culture experiments, although its effects on humans are unknown.</p>

Please enquire for more information about H-Leu-Pro-OH hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

<p>Laminin is a structural protein that provides a scaffold for cell-cell and cell-matrix interactions. Laminin Pentapeptide YIGSR-NH2 is a synthetic peptide that has been shown to be an activator of the laminin receptor and an inhibitor of ion channels. It has also been used as a research tool in studies on antibody production, life science, cell biology, and pharmacology. This peptide is highly pure with no detectable contaminants.</p>

<p>AMP-IBP5, human is a peptide that can be used as a research tool for pharmacological and cell biology studies. It has been shown to inhibit the activity of ion channels, especially those of potassium channels. This peptide also interacts with a number of receptors, including the Ligand-Gated Ion Channel (LGIC), Receptor Tyrosine Kinase (RTK), G Protein-Coupled Receptor (GPCR), and Nuclear Receptor (NR). AMP-IBP5, human is an activator of proteins that are involved in the regulation of cellular signaling pathways. These interactions have been shown to lead to changes in protein expression levels and can be used to study how these proteins interact with each other. AMP-IBP5, human is not active against cells that do not express the receptor or ligand. It has been shown to inhibit the activity of ion channels, especially those of potassium channels. This peptide also</p>

Homoglutathione is a glutathione analog that contains an extra b-alanine residue. Homoglutathione has been shown to be a potent inhibitor of fatty acid synthesis. It inhibits the activity of the enzyme, acetyl-CoA carboxylase, which catalyzes the conversion of acetyl-CoA to malonyl-CoA. Homoglutathione also binds to and inhibits cytoplasmic proteins, such as glutamine synthetase and glutamate synthase. The binding of homoglutathione to these proteins prevents the formation of the active site by preventing the hydrogen bonding between amino acid residues. This process is important in energy metabolism because it regulates the production of ATP from ADP and phosphate.

DBCO-dPEG®12-Meso-TP-IR775 is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. DBCO-dPEG®12-Meso-TP-IR775 is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

<p>1-Naphthalenylsulfonyl-Ile-Trp-aldehyde is a recombinant protein that has protease activity. It is a serine protease that cleaves proteins at the amino acid sequence Ser-Xaa-Gly or Ser-Xaa. The recombinant protein has been shown to have proteolytic activity and can be used in assays to measure the amount of β-catenin, collagen, and growth factor in cells. 1-Naphthalenylsulfonyl-Ile-Trp-aldehyde also binds to monoclonal antibodies and can be used as a neutralizing agent for these proteins. This recombinant protein also has been shown to inhibit the growth of lung fibroblasts.</p>

Protein A/G is a recombinant protein that is used to purify immunoglobulins and other proteins. It has been shown to inhibit binding of IgE to mast cells, which may be due to its ability to bind to the Fc receptor on the surface of these cells. Protein A/G has also been shown to bind with high affinity and specificity to the Fc receptor on human platelets, which may be due to its ability to activate phospholipase C-γ (PLC-γ) in these cells. This activation leads to an increase in intracellular calcium concentrations and subsequent activation of protein kinase C (PKC). Protein A/G binds with high affinity and specificity for membrane-bound receptors for many ligands, such as epidermal growth factor (EGF), transforming growth factor β1 (TGFβ1), erythropoietin (EPO), prolactin, follicle stimulating hormone (FSH), lute